Suppr超能文献

慢性阻塞性肺疾病患者吸入乙酰甲胆碱后肺功能的变化。

Lung function changes following methacholine inhalation in COPD.

机构信息

Division of Infection and Immunity, School of Clinical Sciences, University of Liverpool, University Hospital Aintree, Liverpool, UK.

出版信息

Respir Med. 2009 Apr;103(4):535-41. doi: 10.1016/j.rmed.2008.11.002. Epub 2008 Dec 10.

Abstract

BACKGROUND

The non-specific bronchial hyper-responsiveness reported in mild to moderate COPD is usually attributed to reduced airway calibre accentuating the effect of airway smooth muscle shortening. We hypothesized that in more severe COPD the fall in forced expiratory volume in 1 second (FEV(1)) seen during methacholine challenge would result from an increase in residual volume and decrease in vital capacity rather than an increase in airways resistance.

METHODS

Twenty-five subjects with moderate to severe COPD and 10 asthmatic subjects had spirometry and oscillatory mechanics measured before methacholine challenge and at a 20% fall from baseline post challenge (PC(20)FEV(1)).

RESULTS

In the COPD subjects median PC(20) was 0.35mg/mL. Comparing baseline to PC(20) there were significant falls in forced vital capacity (FVC) (2.91 vs. 2.2L; p<0.001), slow vital capacity (3.22 vs. 2.58L; p<0.001) and IC (2.21 vs. 1.75L; p<0.001) without change in FEV(1)/FVC ratio (0.52 vs. 0.52; not significant) or in total lung capacity where this was measured. Total respiratory system resistance (R(5)) was unchanged (0.66 vs. 0.68; not significant) but total respiratory system reactance decreased significantly (-0.33 vs. -0.44; p<0.001). In contrast, the asthmatics became more obstructed and showed a proportionally smaller fall in lung volume with increase in R(5) (0.43 vs. 0.64; p<0.01).

CONCLUSIONS

In moderate to severe COPD the fall in FEV(1) with methacholine is mainly due to increases in residual volume, which may represent airway closure and new-onset expiratory flow limitation.

摘要

背景

在轻度至中度 COPD 中报告的非特异性支气管高反应性通常归因于气道口径减小,从而加剧气道平滑肌缩短的作用。我们假设在更严重的 COPD 中,乙酰甲胆碱激发试验中用力呼气量 1 秒(FEV1)的下降是由于残气量增加和肺活量减少而不是气道阻力增加所致。

方法

25 例中重度 COPD 患者和 10 例哮喘患者在乙酰甲胆碱激发试验前进行了肺量计和振荡力学测量,并在激发后从基线下降 20%(PC20FEV1)时进行测量。

结果

在 COPD 患者中,PC20 的中位数为 0.35mg/mL。与基线相比,FEV1/FVC 比值无明显变化(0.52 比 0.52;无统计学意义),但 FVC(2.91 比 2.2L;p<0.001)、FVC(3.22 比 2.58L;p<0.001)和 IC(2.21 比 1.75L;p<0.001)均有显著下降,总肺活量也无变化,其中肺活量未测量。总呼吸系统阻力(R5)保持不变(0.66 比 0.68;无统计学意义),但总呼吸系统反应性显著降低(-0.33 比 -0.44;p<0.001)。相比之下,哮喘患者变得更加阻塞,随着 R5 的增加,肺容积的下降比例更小(0.43 比 0.64;p<0.01)。

结论

在中重度 COPD 中,乙酰甲胆碱引起的 FEV1 下降主要是由于残气量增加所致,这可能代表气道关闭和新出现的呼气流量受限。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验